Braun Bettina, Tio Joke, Krause-Bergmann Barbara, Hense Hans-Werner
Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany.
Institute for Cancer Epidemiology, University of Lübeck, Lübeck, Germany.
Front Glob Womens Health. 2023 Jan 16;3:763174. doi: 10.3389/fgwh.2022.763174. eCollection 2022.
The detection of a ductal carcinoma in-situ (DCIS) or an early invasive breast cancer (EIBC), particularly by population-wide mammography-screening-programs, is controversial as an unknown proportion of these cases may be due to overdiagnosis. We investigated whether women with such potentially overdiagnosed breast cancers suffer from sustained adverse psycho-social consequences.
Standardized questionnaires were mailed to 900 survivors, diagnosed with either DCIS or EIBC, requesting self-reports on quality of life using EORTC Quality of Life Questionnaire C-30. Levels of anxiety and depression were assessed using the HADS questionnaires. Item score values in the study group were compared to reference data obtained from normative studies in the German female reference population.
The 577 women who returned completed questionnaires had a mean age of 65.1 years, 387 (67%) had been diagnosed by mammography screening. Median time since diagnosis was 5.9 years. There were no substantial differences between the study sample and the reference population for most of the items. While most score values were even slightly more favorable in the study group, the scores for cognitive function were moderately lower, especially among younger patients. Score values for anxiety were generally higher among younger women (50 to 59 years) from the study group, while depression scores were lower irrespective of age.
This study indicates that the diagnosis of DCIS or EIBC, which is predominantly a result of screening, does not seem to induce sustained, adverse psychological impacts in affected women when compared with the respective general female population. Only anxiety levels remained elevated among younger women.
导管原位癌(DCIS)或早期浸润性乳腺癌(EIBC)的检测,尤其是通过全人群乳腺钼靶筛查项目进行的检测,存在争议,因为这些病例中有未知比例可能是过度诊断所致。我们调查了患有此类可能过度诊断的乳腺癌的女性是否会遭受持续的不良心理社会后果。
向900名被诊断为DCIS或EIBC的幸存者邮寄标准化问卷,要求她们使用欧洲癌症研究与治疗组织生活质量问卷C-30自我报告生活质量。使用医院焦虑抑郁量表(HADS)问卷评估焦虑和抑郁水平。将研究组的项目得分值与从德国女性参考人群的规范性研究中获得的参考数据进行比较。
577名返回完整问卷的女性平均年龄为65.1岁,其中387名(67%)通过乳腺钼靶筛查确诊。自诊断以来的中位时间为5.9年。在大多数项目上,研究样本与参考人群之间没有实质性差异。虽然研究组的大多数得分值甚至略好一些,但认知功能得分适度较低,尤其是在年轻患者中。研究组中年龄在50至59岁的年轻女性的焦虑得分通常较高,而抑郁得分则与年龄无关较低。
本研究表明,与相应的普通女性人群相比,主要由筛查导致的DCIS或EIBC诊断似乎不会对受影响的女性产生持续的不良心理影响。只有年轻女性的焦虑水平仍然较高。